Ligand profile
ZINC32930044
Virtual-screening candidate from ZINC.
Bound to: VK055_0782 — FAD binding domain protein
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC32930044- UniProt (similar protein)
P19643- Tanimoto
- 0.850
- Target protein
- VK055_0782
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 44.9
- −1 ≤ LogP ≤ 5 4.73
- MW ≤ 500 Da 305.2
- LogP ≤ 5 4.73
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 1
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 44.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(Nc1ccc(Cl)c(Cl)c1)c1ccc2cc[nH]c2c1O=C(Nc1ccc(Cl)c(Cl)c1)c1ccc2cc[nH]c2c1
InChI=1S/C15H10Cl2N2O/c16-12-4-3-11(8-13(12)17)19-15(20)10-2-1-9-5-6-18-14(9)7-10/h1-8,18H,(H,19,20)InChI=1S/C15H10Cl2N2O/c16-12-4-3-11(8-13(12)17)19-15(20)10-2-1-9-5-6-18-14(9)7-10/h1-8,18H,(H,19,20)
YZEHYEJZBCFLNJ-UHFFFAOYSA-NYZEHYEJZBCFLNJ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL3319268
- Homolog
- P19643
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC32930044 →
- ZINC ZINC20 ZINC32930044 →
- UniProt UniProt P19643 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC32930044”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0782.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).